111 related articles for article (PubMed ID: 15452259)
21. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial DNA depletion in HIV-infected patients is more pronounced with chronic hepatitis C and enhanced following treatment with pegylated interferon plus ribavirin.
de Mendoza C; Sánchez-Conde M; Timmermans E; Buitelaar M; de Baar MP; Gonzalez-Lahoz J; Soriano V
Antivir Ther; 2005; 10(4):557-61. PubMed ID: 16038482
[TBL] [Abstract][Full Text] [Related]
23. Increased peripheral blood B-cells expressing the CD5 molecules in association to autoantibodies in patients with lupus erythematosus and evidence to selectively down-modulate them.
Böhm I
Biomed Pharmacother; 2004 Jun; 58(5):338-43. PubMed ID: 15194170
[TBL] [Abstract][Full Text] [Related]
24. Peripheral blood memory B cells are resistant to apoptosis in chronic hepatitis C patients.
Mizuochi T; Ito M; Takai K; Yamaguchi K
Virus Res; 2011 Jan; 155(1):349-51. PubMed ID: 20875472
[TBL] [Abstract][Full Text] [Related]
25. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver.
Curry MP; Golden-Mason L; Doherty DG; Deignan T; Norris S; Duffy M; Nolan N; Hall W; Hegarty JE; O'Farrelly C
J Hepatol; 2003 May; 38(5):642-50. PubMed ID: 12713876
[TBL] [Abstract][Full Text] [Related]
26. Functional changes, increased apoptosis, and diminished nuclear factor-kappaB activity of myeloid dendritic cells during chronic hepatitis C infection.
Zhao L; Shields J; Tyrrell DL
Hum Immunol; 2010 Aug; 71(8):751-62. PubMed ID: 20573583
[TBL] [Abstract][Full Text] [Related]
27. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
[TBL] [Abstract][Full Text] [Related]
28. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
29. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
[TBL] [Abstract][Full Text] [Related]
30. Increased killer B cells in chronic HCV infection may lead to autoimmunity and increased viral load.
Eiza N; Zuckerman E; Carlebach M; Rainis T; Goldberg Y; Vadasz Z
Clin Exp Immunol; 2018 Aug; 193(2):183-193. PubMed ID: 29665000
[TBL] [Abstract][Full Text] [Related]
31. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon.
Nishizawa Y; Tanaka E; Orii K; Rokuhara A; Ichijo T; Yoshizawa K; Kiyosawa K
J Gastroenterol Hepatol; 2000 Nov; 15(11):1292-7. PubMed ID: 11129224
[TBL] [Abstract][Full Text] [Related]
32. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Radkowski M; Gallegos-Orozco JF; Jablonska J; Colby TV; Walewska-Zielecka B; Kubicka J; Wilkinson J; Adair D; Rakela J; Laskus T
Hepatology; 2005 Jan; 41(1):106-14. PubMed ID: 15619235
[TBL] [Abstract][Full Text] [Related]
33. A prospective study of lymphocyte subpopulations and regulatory T cells in patients with chronic hepatitis C virus infection developing interferon-induced thyroiditis.
Soldevila B; Alonso N; Martínez-Arconada MJ; Granada ML; Baía D; Vallejos V; Fraile M; Morillas RM; Planas R; Pujol-Borrell R; Martínez-Cáceres EM; Sanmartí AM
Clin Endocrinol (Oxf); 2011 Oct; 75(4):535-43. PubMed ID: 21592168
[TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C.
Umemura T; Wang RY; Schechterly C; Shih JW; Kiyosawa K; Alter HJ
Hepatology; 2006 Jan; 43(1):91-9. PubMed ID: 16323211
[TBL] [Abstract][Full Text] [Related]
35. Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type C.
Akiyama M; Ichikawa T; Miyaaki H; Motoyoshi Y; Takeshita S; Ozawa E; Miuma S; Shibata H; Taura N; Nakao K
Intervirology; 2010; 53(3):154-60. PubMed ID: 20068349
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia.
Cioca DP; Kitano K
Leukemia; 2002 Mar; 16(3):335-43. PubMed ID: 11896536
[TBL] [Abstract][Full Text] [Related]
37. [Late spontaneous elimination of HCV-RNA from mononuclear cells derived from peripheral blood in patients with chronic hepatitis C].
Majda-Stanisławska E; Sidorkiewicz M; Jóźwiak B; Pietrzak A; Brzezińska-Błaszczyk E
Przegl Epidemiol; 2006; 60(1):79-85. PubMed ID: 16758743
[TBL] [Abstract][Full Text] [Related]
38. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF
J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536
[TBL] [Abstract][Full Text] [Related]
39. Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance.
Yee LJ; Kelleher P; Goldin RD; Marshall S; Thomas HC; Alberti A; Chiaramonte M; Braconier JH; Hall AJ; Thursz MR
J Viral Hepat; 2004 Sep; 11(5):459-64. PubMed ID: 15357653
[TBL] [Abstract][Full Text] [Related]
40. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
